Trust Homepage > Pathology Homepage

Test and Tubes Database
ID:916 Rivaoxaban Assay
Search Links: General Info : Protocols : Patient Info

DescriptionRivaoxaban is a new generation oral anticoagulant designed to replace wafarin therapy. The anti-factor Xa assay is used to monitor Rivaoxaban.
IndicationPatients on Rivaoxaban therapy.
Additional InfoRivaoxaban therapy does not usually require monitoring. Some patients however (eg. Children, pregnancy, compliance confirmation) may require levels to be monitored.
Concurrent TestsNone
Dietary Requirementsna

InterpretationInterpreted against a therapeutic range dependent on clinical details

Ref. Range (Male)
Ref. Range (Female)
Ref. Range (Paed)
Ref. Range NotesInterpreted against a therapeutic range dependent on clinical details Critical telephone values: Rivaroxaban anti-Xa greater than 550ng/mL

Other Help:National Laboratory Medicine Handbook

IP Acute TAT- Contact Laboratory
IP Routine TAT24 hours
GP Acute TAT- Contact Laboratory
GP Routine TAT24 hours
Turnround CommentSpecialist test only to be requested by a medical haematologist.
Originally edited by : RJAR. Last edited on 18/06/2019 10:38:38. Published By RJAR on 18/06/2018 10:38:38.